Literature DB >> 25375653

Is it time for BRCA1/2 mutation screening in the general adult population?: impact of population characteristics.

Glenn E Palomaki1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25375653     DOI： 10.1038/gim.2014.167

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  8 in total

1.  Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: public health implications.

Authors:  Monica R McClain; Glenn E Palomaki; Katherine L Nathanson; James E Haddow
Journal:  Genet Med       Date:  2005-01       Impact factor: 8.822

2.  An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish women.

Authors:  Monica R McClain; Katherine L Nathanson; Glenn E Palomaki; James E Haddow
Journal:  Genet Med       Date:  2005-01       Impact factor: 8.822

Review 3.  Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2005-09-06       Impact factor: 25.391

4.  Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.

Authors:  Mary-Claire King; Ephrat Levy-Lahad; Amnon Lahad
Journal:  JAMA       Date:  2014-09-17       Impact factor: 56.272

5.  Reporting the assessment of screening and diagnostic tests.

Authors:  N Wald; H Cuckle
Journal:  Br J Obstet Gynaecol       Date:  1989-04

6.  Identification of the breast cancer susceptibility gene BRCA2.

Authors:  R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

7.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

8.  Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.

Authors:  Efrat Gabai-Kapara; Amnon Lahad; Bella Kaufman; Eitan Friedman; Shlomo Segev; Paul Renbaum; Rachel Beeri; Moran Gal; Julia Grinshpun-Cohen; Karen Djemal; Jessica B Mandell; Ming K Lee; Uziel Beller; Raphael Catane; Mary-Claire King; Ephrat Levy-Lahad
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-05       Impact factor: 11.205
  8 in total
  5 in total

Review 1.  Population genetic testing for cancer susceptibility: founder mutations to genomes.

Authors:  William D Foulkes; Bartha Maria Knoppers; Clare Turnbull
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

Review 2.  Ovarian Cancer Prevention in High-risk Women.

Authors:  Sarah M Temkin; Jennifer Bergstrom; Goli Samimi; Lori Minasian
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

3.  Second primary cancer after female breast cancer: Familial risks and cause of death.

Authors:  Guoqiao Zheng; Akseli Hemminki; Asta Försti; Jan Sundquist; Kristina Sundquist; Kari Hemminki
Journal:  Cancer Med       Date:  2018-11-26       Impact factor: 4.452

4.  Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study.

Authors:  Charlotte Warren-Gash; Mark Kroese; Hilary Burton; Paul Pharoah
Journal:  Hered Cancer Clin Pract       Date:  2016-06-01       Impact factor: 2.857

5.  Familial risks of second primary cancers and mortality in ovarian cancer patients.

Authors:  Guoqiao Zheng; Subhayan Chattopadhyay; Asta Försti; Kristina Sundquist; Kari Hemminki
Journal:  Clin Epidemiol       Date:  2018-10-11       Impact factor: 4.790
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.